Staying Ahead of Scleroderma-ILD: Understanding Progression and Your Treatment Options

Scleroderma-associated interstitial lung disease (SSc-ILD) is a serious complication that occurs when there is inflammation and scarring to the lung tissue, and can affect breathing.

In this session, Toby Maher, MD, PhD (Keck School of Medicine of the University of Southern California), covered how SSc-ILD progression is recognized, the signs patients and clinicians watch for, and how that recognition shapes treatment decisions.

Held in recognition of ILD Day, this session was originally presented on September 15, 2026. As part of the ILD Day campaign, the SRF was proud to stand alongside a coalition of partner organizations uniting under one shared goal: raising ILD awareness and connecting people with trusted resources and support.